Showing 101-110 of 120 results for "".
Resolution of Primary Erythromelalgia Following Ibuprofen; Fire Power
https://practicaldermatology.com/youngmd-connect/resident-resource-center/resolution-of-primary-erythromelalgia-following-ibuprofen-fire-power/20619/Calcium Dependence of the SHH Pathway and Theoretical Implications in Oral Treatment of Locally Advanced or Metastatic Basal Cell Carcinomas
https://practicaldermatology.com/issues/supplements/calcium-dependence-of-the-shh-pathway-and-theoretical-implications-in-oral-treatment-of-locally-advanced-or-metastatic-basal-cell-carcinomas/21719/A Review of Complications of Biologic Therapy for Psoriasis
https://practicaldermatology.com/topics/general-topics/1109_02-php/22053/Therapeutic success requires clinicians to understand emerging and established safety concerns.Complications of Biologic Therapy for Psoriasis: Part II
https://practicaldermatology.com/topics/psoriasis/complications-of-biologic-therapy-for-psoriasis-part-ii/22039/Therapeutic success requires clinicians to understand emerging and established safety concerns.A Multidisciplinary Toolbox for Atopic Dermatitis Treatments
https://practicaldermatology.com/topics/atopic-dermatitis/a-multidisciplinary-toolbox-for-atopic-dermatitis-treatments/23445/- Vial Dermatology CRO adds Dr. Jonathan Zung to Scientific Advisory Boardhttps://practicaldermatology.com/news/vial-dermatology-cro-adds-dr-jonathan-zung-to-scientific-advisory-boar/2461236/The Vial Dermatology CRO welcomed Jonathan Zung, PhD, as the newest addition to the Vial Scientific Advisory Board. Dr. Zung will support the Vial CRO team and their sponsors to further advance the field of dermatology clinical researc
- Special Report: An Overview of Coronavirus by Dr. Jonathan Kaplanhttps://practicaldermatology.com/news/special-report-an-overview-of-coronavirus-by-dr-jonathan-kaplan/2460306/Wash your hands, wipe down surfaces, don’t touch your face, and practice social distancing. If nothing else, that’s what you should take away from this coronavirus overview. But keep reading to learn important details about this epidemic. Such as, how we can make it end with less coll
- Beyond the Headlines: Dr. Jonathan Silverberg Reviews Maintenance Data on Rademikibart From a Pivotal Trial in Chinahttps://practicaldermatology.com/news/beyond-the-headlines-dr-jonathan-silverberg-reviews-maintenance-data-on-rademikibart-from-a-pivotal-trial-in-china/2462152/DermWire recently reported positive topline results from a 52-week maintenance study of rademikibart in people with atopic dermatitis (AD). At
- Dupilumab Produces Early and Sustained Improvements in CSU Activityhttps://practicaldermatology.com/news/dupilumab-produces-early-and-sustained-improvements-in-csu-activity/2485548/Dupilumab produced early and sustained reductions in urticaria activity in patients with chronic spontaneous urticaria (CSU), according to “Dupilumab Provides Early and Sustained Improvement in Urticaria Activity in Patients With Chronic Spontaneous Urticaria,” a poster by Jonathan A. Bernstein,
- Pennsylvania Passes SUNucate, Allowing Sunscreen Use and Protective Clothing at Schoolhttps://practicaldermatology.com/news/pennsylvania-passes-sunucate-allowing-sunscreen-use-and-protective-clothing-at-school/2457529/Pennsylvania became the 17th state to allow children to possess and apply sunscreen at school. Governor Tom Wolf approved HB 1228, a piece of legislation based on American Society for Dermatologic Surgery Association’s (ASDA) model bill known as SUNucate<